These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 17936076)

  • 1. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain.
    Daniell HW
    J Pain; 2008 Jan; 9(1):28-36. PubMed ID: 17936076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production.
    Daniell HW
    J Pain; 2006 Dec; 7(12):901-7. PubMed ID: 17157776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine consequences of long-term intrathecal administration of opioids.
    Abs R; Verhelst J; Maeyaert J; Van Buyten JP; Opsomer F; Adriaensen H; Verlooy J; Van Havenbergh T; Smet M; Van Acker K
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2215-22. PubMed ID: 10852454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single opioid administration modifies gonadal steroids in both the CNS and plasma of male rats.
    Ceccarelli I; De Padova AM; Fiorenzani P; Massafra C; Aloisi AM
    Neuroscience; 2006 Jul; 140(3):929-37. PubMed ID: 16580783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid-induced androgen deficiency (OPIAD).
    Smith HS; Elliott JA
    Pain Physician; 2012 Jul; 15(3 Suppl):ES145-56. PubMed ID: 22786453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids and hypogonadism.
    Prescrire Int; 2012 Apr; 21(126):98-9. PubMed ID: 22515135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypogonadism in patients treated with intrathecal morphine.
    Finch PM; Roberts LJ; Price L; Hadlow NC; Pullan PT
    Clin J Pain; 2000 Sep; 16(3):251-4. PubMed ID: 11014399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment.
    Rhodin A; Stridsberg M; Gordh T
    Clin J Pain; 2010 Jun; 26(5):374-80. PubMed ID: 20473043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids.
    Rajagopal A; Vassilopoulou-Sellin R; Palmer JL; Kaur G; Bruera E
    Cancer; 2004 Feb; 100(4):851-8. PubMed ID: 14770444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen deficiency in long-term intrathecal opioid administration.
    Kim CH; Garcia R; Stover J; Ritchie K; Whealton T; Ata MA
    Pain Physician; 2014; 17(4):E543-8. PubMed ID: 25054405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid-induced endocrinopathy.
    Colameco S; Coren JS
    J Am Osteopath Assoc; 2009 Jan; 109(1):20-5. PubMed ID: 19193821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypogonadism in men consuming sustained-action oral opioids.
    Daniell HW
    J Pain; 2002 Oct; 3(5):377-84. PubMed ID: 14622741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids.
    Rubinstein AL; Carpenter DM; Minkoff JR
    Clin J Pain; 2013 Oct; 29(10):840-5. PubMed ID: 24384986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency.
    Daniell HW; Lentz R; Mazer NA
    J Pain; 2006 Mar; 7(3):200-10. PubMed ID: 16516826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid-induced hypogonadism: why and how to treat it.
    De Maddalena C; Bellini M; Berra M; Meriggiola MC; Aloisi AM
    Pain Physician; 2012 Jul; 15(3 Suppl):ES111-8. PubMed ID: 22786450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the endocrine manifestations of hepatic cirrhosis.
    Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
    Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of opioid therapy on endocrine function.
    Brennan MJ
    Am J Med; 2013 Mar; 126(3 Suppl 1):S12-8. PubMed ID: 23414717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid Related Endocrinopathy.
    Gudin JA; Laitman A; Nalamachu S
    Pain Med; 2015 Oct; 16 Suppl 1():S9-15. PubMed ID: 26461076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.